Review



anti rrv mouse ascites fluid  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    ATCC anti rrv mouse ascites fluid
    Anti Rrv Mouse Ascites Fluid, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 21 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rrv mouse ascites fluid/product/ATCC
    Average 91 stars, based on 21 article reviews
    anti rrv mouse ascites fluid - by Bioz Stars, 2026-02
    91/100 stars

    Images



    Similar Products

    91
    ATCC anti rrv mouse ascites fluid
    Anti Rrv Mouse Ascites Fluid, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti rrv mouse ascites fluid/product/ATCC
    Average 91 stars, based on 1 article reviews
    anti rrv mouse ascites fluid - by Bioz Stars, 2026-02
    91/100 stars
      Buy from Supplier

    91
    ATCC rrv mouse ascites fluid
    Rrv Mouse Ascites Fluid, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rrv mouse ascites fluid/product/ATCC
    Average 91 stars, based on 1 article reviews
    rrv mouse ascites fluid - by Bioz Stars, 2026-02
    91/100 stars
      Buy from Supplier

    91
    ATCC mouse rrv immune ascites fluid
    ( A ) 293T cells were transfected with the <t>RRV</t> structural genes, stained using CHK-265 human IgG1, CHIKV <t>immune</t> <t>IgG,</t> or IgG isolated from healthy controls (healthy control IgG), and analyzed by flow cytometry. An anti-RRV mAb (RRV-130; 10 μg/ml) and human isotype control (WNV hE16; 10 μg/ml) were included as positive and negative controls, respectively. ( B ) Neutralization assay. Purified polyclonal CHIKV-immune IgG was preincubated with 10 2 FFU of RRV or CHIKV-LR then added to Vero cells for 20 or 18 h, respectively. Viral foci were counted and compared to wells without mAb to determine relative infection. Purified IgG from healthy individuals (healthy control IgG) was included as a negative control. ( C - E ) Three-week-old male and female WT mice were administered 300 μg of purified human CHIKV immune IgG or healthy control IgG one day prior to infection with 10 3 FFU RRV. ( C ) Weights were followed for 15 dpi. Graph shows mean ±SEM (n = 5–6 per group; two experiments; student’s t-test of AUC analysis: **** P < 0.0001). ( D ) Serum was collected 1 and 3 dpi and titered by qRT-PCR. ( E ) Viral RNA was quantified from spleen, ipsilateral (i.) and contralateral (c.) quadriceps muscles (quad), and ipsilateral and contralateral ankle at 15 dpi using qRT-PCR. ( D-E ) Bars represent the median (n = 5–6 per group; two experiments; Mann-Whitney test; * P < 0.05, ** P < 0.01). Colored circles indicate CHIKV immune IgG treated mouse with identified RRV variant at 3 dpi: orange circle: E2-K189Q mutation; green circle: E2-D214A mutation. ( F , G ) 293T cells were transfected with the WT, E2-D214A, or E2-K189Q RRV structural genes, stained with ( F ) CHK-265 human IgG1, anti-RRV mAb [RRV-130; 0.04 μg/ml (EC 80 )], human isotype control (WNV hE16), ( G ) CHIKV immune IgG, or healthy control IgG at 30 μg/ml unless otherwise noted, and analyzed by flow cytometry. Relative integrated mean fluorescence intensity (iMFI) was calculated by multiplying the percent positive cells and the median fluorescence intensity for each RRV variant and comparing it to the RRV WT control. Bars indicate mean (four experiments performed in duplicate; One-way ANOVA with a Holm-Sidak’s post-test comparing RRV variants to WT; * P < 0.05, **** P < 0.0001). Ab: antibody.
    Mouse Rrv Immune Ascites Fluid, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse rrv immune ascites fluid/product/ATCC
    Average 91 stars, based on 1 article reviews
    mouse rrv immune ascites fluid - by Bioz Stars, 2026-02
    91/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) 293T cells were transfected with the RRV structural genes, stained using CHK-265 human IgG1, CHIKV immune IgG, or IgG isolated from healthy controls (healthy control IgG), and analyzed by flow cytometry. An anti-RRV mAb (RRV-130; 10 μg/ml) and human isotype control (WNV hE16; 10 μg/ml) were included as positive and negative controls, respectively. ( B ) Neutralization assay. Purified polyclonal CHIKV-immune IgG was preincubated with 10 2 FFU of RRV or CHIKV-LR then added to Vero cells for 20 or 18 h, respectively. Viral foci were counted and compared to wells without mAb to determine relative infection. Purified IgG from healthy individuals (healthy control IgG) was included as a negative control. ( C - E ) Three-week-old male and female WT mice were administered 300 μg of purified human CHIKV immune IgG or healthy control IgG one day prior to infection with 10 3 FFU RRV. ( C ) Weights were followed for 15 dpi. Graph shows mean ±SEM (n = 5–6 per group; two experiments; student’s t-test of AUC analysis: **** P < 0.0001). ( D ) Serum was collected 1 and 3 dpi and titered by qRT-PCR. ( E ) Viral RNA was quantified from spleen, ipsilateral (i.) and contralateral (c.) quadriceps muscles (quad), and ipsilateral and contralateral ankle at 15 dpi using qRT-PCR. ( D-E ) Bars represent the median (n = 5–6 per group; two experiments; Mann-Whitney test; * P < 0.05, ** P < 0.01). Colored circles indicate CHIKV immune IgG treated mouse with identified RRV variant at 3 dpi: orange circle: E2-K189Q mutation; green circle: E2-D214A mutation. ( F , G ) 293T cells were transfected with the WT, E2-D214A, or E2-K189Q RRV structural genes, stained with ( F ) CHK-265 human IgG1, anti-RRV mAb [RRV-130; 0.04 μg/ml (EC 80 )], human isotype control (WNV hE16), ( G ) CHIKV immune IgG, or healthy control IgG at 30 μg/ml unless otherwise noted, and analyzed by flow cytometry. Relative integrated mean fluorescence intensity (iMFI) was calculated by multiplying the percent positive cells and the median fluorescence intensity for each RRV variant and comparing it to the RRV WT control. Bars indicate mean (four experiments performed in duplicate; One-way ANOVA with a Holm-Sidak’s post-test comparing RRV variants to WT; * P < 0.05, **** P < 0.0001). Ab: antibody.

    Journal: PLoS Pathogens

    Article Title: A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice

    doi: 10.1371/journal.ppat.1008743

    Figure Lengend Snippet: ( A ) 293T cells were transfected with the RRV structural genes, stained using CHK-265 human IgG1, CHIKV immune IgG, or IgG isolated from healthy controls (healthy control IgG), and analyzed by flow cytometry. An anti-RRV mAb (RRV-130; 10 μg/ml) and human isotype control (WNV hE16; 10 μg/ml) were included as positive and negative controls, respectively. ( B ) Neutralization assay. Purified polyclonal CHIKV-immune IgG was preincubated with 10 2 FFU of RRV or CHIKV-LR then added to Vero cells for 20 or 18 h, respectively. Viral foci were counted and compared to wells without mAb to determine relative infection. Purified IgG from healthy individuals (healthy control IgG) was included as a negative control. ( C - E ) Three-week-old male and female WT mice were administered 300 μg of purified human CHIKV immune IgG or healthy control IgG one day prior to infection with 10 3 FFU RRV. ( C ) Weights were followed for 15 dpi. Graph shows mean ±SEM (n = 5–6 per group; two experiments; student’s t-test of AUC analysis: **** P < 0.0001). ( D ) Serum was collected 1 and 3 dpi and titered by qRT-PCR. ( E ) Viral RNA was quantified from spleen, ipsilateral (i.) and contralateral (c.) quadriceps muscles (quad), and ipsilateral and contralateral ankle at 15 dpi using qRT-PCR. ( D-E ) Bars represent the median (n = 5–6 per group; two experiments; Mann-Whitney test; * P < 0.05, ** P < 0.01). Colored circles indicate CHIKV immune IgG treated mouse with identified RRV variant at 3 dpi: orange circle: E2-K189Q mutation; green circle: E2-D214A mutation. ( F , G ) 293T cells were transfected with the WT, E2-D214A, or E2-K189Q RRV structural genes, stained with ( F ) CHK-265 human IgG1, anti-RRV mAb [RRV-130; 0.04 μg/ml (EC 80 )], human isotype control (WNV hE16), ( G ) CHIKV immune IgG, or healthy control IgG at 30 μg/ml unless otherwise noted, and analyzed by flow cytometry. Relative integrated mean fluorescence intensity (iMFI) was calculated by multiplying the percent positive cells and the median fluorescence intensity for each RRV variant and comparing it to the RRV WT control. Bars indicate mean (four experiments performed in duplicate; One-way ANOVA with a Holm-Sidak’s post-test comparing RRV variants to WT; * P < 0.05, **** P < 0.0001). Ab: antibody.

    Article Snippet: Cells were fixed at 20 to 22 hpi and stained with mouse RRV immune ascites fluid (ATCC) followed by an anti-mouse IgG conjugated to HRP.

    Techniques: Transfection, Staining, Isolation, Control, Flow Cytometry, Neutralization, Purification, Infection, Negative Control, Quantitative RT-PCR, Muscles, MANN-WHITNEY, Variant Assay, Mutagenesis, Fluorescence